Patent details

Basic Information

Publication number:

EP4169508

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP221870298

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITIONS COMPRISING ALPELISIB

French Title of Invention:

COMPOSITIONS PHARMACEUTIQUES CONTENANT DE L'ALPÉLISIB

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT ALPELISIB

SPC Number:

Dates

Filing date:

01/10/2015

Grant date:

20/05/2026

EP Publication Date:

26/04/2023

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

20/05/2026

EP B1 Publication Date:

20/05/2026

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

01/10/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

13/05/2026

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

Kochhar, Charu

Address:

Switzerland (CH)

2

Name:

Bock, Michaela Anna Maria

Address:

Switzerland (CH)

3

Name:

Elbaz, Frantz

Address:

Switzerland (CH)

4

Name:

Stingelin, Doris

Address:

Switzerland (CH)

Priority

Priority Number:

201462059331 P

Priority Date:

03/10/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/20; A61K 31/4439; A61K 31/454; A61P 35/00; A61P 35/02; A61P 43/00; A61J 3/10;

Publication

European Patent Bulletin

Issue number:

202621

Publication date:

20/05/2026

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

02/11/2026

Annual Fee Number:

12

Annual Fee Amount:

165 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages